9-Bromo-5,6-dihydro-dibenzo[b,f]azocine

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 9-Bromo-5,6-dihydro-dibenzo[b,f]azocine
• 英文别名: (11Z)-9-bromo-5,6-dihydrobenzo[c][1]benzazocine
• 化学式: C₁₅H₁₂BrN
• 分子量: 286.171
• InChiKey: YFIMTUBFVPWLJN-WAYWQWQTSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  17
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  9-Bromo-5,6-dihydro-dibenzo[b,f]azocine 在 Rh on carbon 氢气 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 生成 1-(9-bromo-11,12-dihydro-6H-dibenzo[b,f]azocin-5-yl)-ethanone
  参考文献：
  名称：

  Identification of a novel series of tetrahydrodibenzazocines as inhibitors of 17β-hydroxysteroid dehydrogenase type 3

  摘要：

  A novel series of 17 beta-hydroxysteroid dehydrogenase type 3 (17 beta-HSD3) inhibitors has been identified. These inhibitors, based on a dibenzazocine core, exhibited picomolar to low nanomolar inhibition of 17 beta-HSD3 in cell-free enzymatic as well as in cell-based transcriptional reporter assays. (C) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.12.039
• 作为产物：
  描述：

  5-溴茚酮 在 盐酸 、 dimethyl sulfide borane 、 硫酸 、 溶剂黄146 、 间氯过氧苯甲酸 作用下， 以 乙醇 、 二氯甲烷 、 甲苯 为溶剂， 生成 9-Bromo-5,6-dihydro-dibenzo[b,f]azocine
  参考文献：
  名称：

  Identification of a novel series of tetrahydrodibenzazocines as inhibitors of 17β-hydroxysteroid dehydrogenase type 3

  摘要：

  A novel series of 17 beta-hydroxysteroid dehydrogenase type 3 (17 beta-HSD3) inhibitors has been identified. These inhibitors, based on a dibenzazocine core, exhibited picomolar to low nanomolar inhibition of 17 beta-HSD3 in cell-free enzymatic as well as in cell-based transcriptional reporter assays. (C) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.12.039

文献信息

• Fused tricyclic compounds as inhibitors of 17beta-hydroxysteroid dehydrogenase 3
  申请人：Fink E. Brian

  公开号：US20050250753A1

  公开（公告）日：2005-11-10

  Fused tricyclic compounds, methods of using such compounds in the treatment of hormone sensitive diseases such as prostate cancer, and pharmaceutical compositions containing such compounds.

  融合三环化合物，使用这种化合物治疗激素敏感性疾病如前列腺癌的方法，以及含有这种化合物的药物组合物。
• FUSED TRICYCLIC COMPOUNDS AS INHIBITORS OF 17BETA-HYDROXYSTEROID DEHYDROGERNASE 3
  申请人：Bristol-Myers Squibb Company

  公开号：EP1720613A2

  公开（公告）日：2006-11-15
• EP1720613A4
  申请人：——

  公开号：EP1720613A4

  公开（公告）日：2009-05-06
• US7417040B2
  申请人：——

  公开号：US7417040B2

  公开（公告）日：2008-08-26
• [EN] FUSED TRICYCLIC COMPOUNDS AS INHIBITORS OF 17BETA-HYDROXYSTEROID DEHYDROGERNASE 3<br/>[FR] COMPOSES TRICYCLIQUES FUSIONNES EN TANT QU'INHIBITEURS DE 17BETA-HYDROXYSTEROIDE DESHYDROGENASE 3
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2005084296A2

  公开（公告）日：2005-09-15

  Fused tricyclic compounds, methods of using such compounds in the treatment of hormone sensitive diseases such as prostate cancer, and pharmaceutical compositions containing such compounds.